NetEase, Inc. (NASDAQ:NTES) is on recovery track with 62.98% gain from a 1-year low price of $211.11. The company lost -6.38% to attain the price of $344.07 on 11/20/2017. Throughout the recent session, the prices were hovering between $338.52 and $363. These shares are -7.19% up from its target price of $319.32 and the current market capitalization stands at $45.34B. The recent change has given its price a 21.93% lead over SMA 50 and -8.27% deficit over its 52-week high. The stock witnessed 24.38% gains, 24.21% gains and 17.72% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found NTES’s volatility during a week at 6.37% and during a month it has been found around 4.02%.NetEase, Inc. (NTES) Top Holders
Institutional investors currently hold around $23.83 billion or 53.2% in NTES stock. Look at its top three institutional owners. Blackrock Inc. owns $1.73 billion in NetEase, Inc., which represents roughly 3.83% of the company’s market cap and approximately 7.28% of the institutional ownership. Similar statistics are true for the second largest owner, Invesco Ltd., which owns 3,760,476 shares of the stock are valued at $1.38 billion. The third largest holder is Lazard Asset Management Llc, which currently holds $1.18 billion worth of this stock and that ownership represents nearly 2.6% of its market capitalization.NetEase, Inc. 13F Filings
At the end of 09/30/2017 reporting period, 203 institutional holders increased their position in NetEase, Inc. (NASDAQ:NTES) by some 8,947,553 shares, 234 decreased positions by 10,577,578 and 53 held positions by 45,321,670. That puts total institutional holdings at 64,846,801 shares, according to SEC filings. The stock grabbed 48 new institutional investments totaling 1,581,150 shares while 72 institutional investors sold out their entire positions totaling 2,445,464 shares.NetEase, Inc. (NTES) Analyst Guide
Several analysts have released their opinion on NetEase, Inc. (NASDAQ:NTES), with 3 analysts believing it is a strong buy. Whereas 4 of them predict the stock is a hold. Also, there are 0 buy, 0 sell and 0 strong sell ratings, collectively assigning a 2.14 average brokerage recommendation.